Ignite Creation Date:
2025-12-25 @ 1:39 AM
Ignite Modification Date:
2026-01-03 @ 5:26 PM
Study NCT ID:
NCT01478594
Status:
COMPLETED
Last Update Posted:
2015-07-08
First Post:
2011-11-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy
Sponsor:
AVEO Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-12
Start Date Type:
None
Primary Completion Date:
2013-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-01
Completion Date Type:
ACTUAL
First Submit Date:
2011-11-21
First Submit QC Date:
None
Study First Post Date:
2011-11-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-02-19
Results First Submit QC Date:
None
Results First Post Date:
2015-04-03
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-06-09
Last Update Post Date:
2015-07-08
Last Update Post Date Type:
ESTIMATED